共 50 条
- [22] Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial [J]. LANCET DIABETES & ENDOCRINOLOGY, 2015, 3 (08): : 595 - 604
- [24] Outpatient 60-hour day-and-night glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or sensor-augmented pump therapy in adults with type 1 diabetes: An open-label, randomised, crossover, controlled trial [J]. DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 713 - 720
- [26] Impact of erroneous meal insulin bolus with dual-hormone artificial pancreas using a simplified bolus strategy - A randomized controlled trial [J]. SCIENTIFIC REPORTS, 2018, 8